Evaluating the Safety and Immunogenicity of an HIV-1 gp41 MPER-656 Liposome Vaccine in Healthy, HIV-uninfected Adult Participants
Clinical trial NCT03934541 · COMPLETED
Trial details
- NCT number
- NCT03934541
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-26
- Primary completion
- 2021-02-05
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.